“Very difficult" for US competitors in Europe, says boss of healthtech Tandem Health
Summary
Tandem Health, a Sweden-based healthtech startup, asserts that US competitors face significant challenges in the European market due to a growing preference among European healthcare providers for local businesses. Tandem's co-founder, Lukas Saari, highlighted the company's "full European focus," including its investor base, as a key competitive advantage. Tandem Health, which employs approximately 170 people, utilizes Large Language Models (LLMs) to power an AI co-pilot for clinicians, generating medical notes, referral notes, and patient communications. The company secured a $10 million seed round in 2024 and a $50 million Series A round in July last year, with the UK's NHS being its largest market by user numbers.
Key takeaway
For entrepreneurs considering market entry into European healthtech, prioritize establishing a strong local presence and securing European-based investors. Your ability to align with regional preferences for European businesses can significantly differentiate you from US-based competitors, especially in public service procurement. Focus on developing AI solutions that address specific clinical workflows, such as medical note-taking and patient communication.
Key insights
European healthtech companies with local focus gain a competitive edge over US rivals in the European market.
Principles
- Local market focus aids European healthtech adoption.
- LLMs can power comprehensive medical AI assistants.
In practice
- Develop AI co-pilots for medical note generation.
- Expand AI assistant features to include patient communications.
Topics
- Tandem Health
- Healthtech Europe
- Large Language Models
- AI Co-pilot
- Clinical Workflow Automation
Best for: Entrepreneur, Director of AI/ML, AI Product Manager, Investor
Related on AIssential
Editorial summary, takeaway, and curation by AIssential. Original article published by Tech.eu - Tech.eu.